ADVANCES IN PSORIASIS TREATMENT: COMBINING SECUKINUMAB WITH PHOTOTHERAPY

This article explores the benefits of combining secukinumab, a biologic IL-17 inhibitor, with narrowband UVB phototherapy in treating moderate to severe psoriasis. It presents findings from five patients who demonstrated significant skin clearance and improved quality of life through this combination approach, suggesting that it can be an effective treatment for resistant forms of the disease

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-18
DOI
https://doi.org/10.5281/zenodo.13952564
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ADVANCES IN PSORIASIS TREATMENT: COMBINING SECUKINUMAB WITH PHOTOTHERAPY

Zenodo (CERN European Organization for Nuclear Research)
Psoriasis: Treatment and Pathogenesis
article

ADVANCES IN PSORIASIS TREATMENT: COMBINING SECUKINUMAB WITH PHOTOTHERAPY

article en

Abstract

This article explores the benefits of combining secukinumab, a biologic IL-17 inhibitor, with narrowband UVB phototherapy in treating moderate to severe psoriasis. It presents findings from five patients who demonstrated significant skin clearance and improved quality of life through this combination approach, suggesting that it can be an effective treatment for resistant forms of the disease

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 54%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ADVANCES IN PSORIASIS TREATMENT: COMBINING SECUKINUMAB WITH PHOTOTHERAPY · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS